Ko Fujimori
- Molecular Biology top 5%
- Pharmacology top 2%
- Physiology top 5%
- Epidemiology top 10%
- Biochemistry top 1%
- Co-authors
- Yoshihiro UradeFumio AmanoKosuke AritakeMakio ShibanoYuta MorishigeDaisaku OhtaOsamu HayaishiAtsushi Koike
- Topics
- Peroxisome Proliferator-Activated Receptors (20 papers)Inflammatory mediators and NSAID effects (19 papers)Drug Transport and Resistance Mechanisms (12 papers)
- Partner nations
- JapanUnited StatesBrazil
In The Last Decade
Ko Fujimori
96 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 130
- Molecular Biology 1.5k
- Pharmacology 508
- Physiology 433
- Epidemiology 374
- Biochemistry 305
Countries citing papers authored by Ko Fujimori
This map shows the geographic impact of Ko Fujimori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ko Fujimori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ko Fujimori more than expected).
Fields of papers citing papers by Ko Fujimori
This network shows the impact of papers produced by Ko Fujimori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ko Fujimori. The network helps show where Ko Fujimori may publish in the future.
Co-authorship network of co-authors of Ko Fujimori
This figure shows the co-authorship network connecting the top 25 collaborators of Ko Fujimori. A scholar is included among the top collaborators of Ko Fujimori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ko Fujimori. Ko Fujimori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 15 | |
| 4 | 22 | |
| 5 | 4 | |
| 6 | 20 | |
| 7 | 9 | |
| 8 | 30 | |
| 9 | 19 | |
| 10 | 25 | |
| 11 | 32 | |
| 12 | 25 | |
| 13 | 23 | |
| 14 | 7 | |
| 15 | 56 | |
| 16 | 45 | |
| 17 | 56 | |
| 18 | 25 | |
| 19 | 92 | |
| 20 | 79 |
About Ko Fujimori
Ko Fujimori is a scholar working on Pharmacology, Biochemistry and Molecular Biology, having authored 98 papers that have together received 2.9k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (20 papers), Inflammatory mediators and NSAID effects (19 papers) and Drug Transport and Resistance Mechanisms (12 papers). The work is most often cited by research in Biochemistry (305 citations), Pharmacology (508 citations) and Molecular Biology (1.5k citations). Ko Fujimori has collaborated with scholars based in Japan, United States and Brazil. Frequent co-authors include Yoshihiro Urade, Fumio Amano, Kosuke Aritake, Makio Shibano, Yuta Morishige, Daisaku Ohta, Osamu Hayaishi, Atsushi Koike, Fernando C. Reinach and Takashi Inui. Their work appears in journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.